XML 21 R23.htm IDEA: XBRL DOCUMENT
v3.19.3

Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries | 9 Months Ended
--- | ---
Sep. 30, 2019
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries [Abstract] |
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries | Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries We conduct substantially all of our business through our U.S. and foreign subsidiaries. As of September 30, 2019, SGI’s obligations under the Secured Notes (other than the 2022 Secured Notes, which were redeemed in March 2018), the Unsecured Notes and the Subordinated Notes were fully and unconditionally and jointly and severally guaranteed by SGC and the Guarantor Subsidiaries other than SGI, and certain immaterial subsidiaries of SGC. The guarantees of our Secured Notes (other than the 2022 Secured Notes, which were redeemed in March 2018), Unsecured Notes and Subordinated Notes will terminate under the following customary circumstances: (1) the sale or disposition of the capital stock of the guarantor (including by consolidation or merger of the guarantor into another person); (2) the liquidation or dissolution of the guarantor; (3) the defeasance or satisfaction and discharge of the notes; (4) the release of the guarantor from any guarantees of indebtedness of SGC and SGI; and (5) the proper designation of the guarantor as an unrestricted subsidiary pursuant to the indenture governing the respective notes. Presented below is condensed consolidating financial information for (1) SGC, (2) SGI, (3) the Guarantor Subsidiaries and (4) the Non-Guarantor Subsidiaries as of September 30, 2019 and December 31, 2018 and for the three and nine months ended September 30, 2019 and 2018. The condensed consolidating financial information has been presented to show the nature of assets held, results of operations and cash flows of SGC, SGI, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries assuming the current guarantee structures of the Secured Notes (other than the 2022 Secured Notes, which were redeemed in March 2018), the Unsecured Notes and the Subordinated Notes were in effect at the beginning of the periods presented. The condensed consolidating financial information reflects the investments of SGC in SGI, the Guarantor Subsidiaries and the Non-Guarantor Subsidiaries using the equity method of accounting. They also reflect the investments of the Guarantor Subsidiaries in the Non-Guarantor Subsidiaries. Net changes in intercompany due from/due to accounts are reported in the accompanying Supplemental Condensed Consolidating Statements of Cash Flows as investing activities if the applicable entities have a net investment (asset) in intercompany accounts and as a financing activity if the applicable entities have a net intercompany borrowing (liability) balance. SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET As of September 30, 2019
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Assets |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 194 |  |  | $ | — |  |  | $ | — |  |  | $ | 170 |  |  | $ | (1 | ) |  | $ | 363 |
Restricted cash | — |  |  | 1 |  |  | 37 |  |  | 8 |  |  | — |  |  | 46 |
Accounts receivable, net | — |  |  | 105 |  |  | 193 |  |  | 338 |  |  | — |  |  | 636 |
Notes receivable, net | — |  |  | — |  |  | 110 |  |  | 13 |  |  | — |  |  | 123 |
Inventories | — |  |  | 53 |  |  | 114 |  |  | 103 |  |  | (13 | ) |  | 257 |
Prepaid expenses, deposits and other current assets | 6 |  |  | 57 |  |  | 70 |  |  | 92 |  |  | 1 |  |  | 226 |
Property and equipment, net | 32 |  |  | 95 |  |  | 223 |  |  | 197 |  |  | (31 | ) |  | 516 |
Operating lease right-of-use asset | 1 |  |  | 24 |  |  | 32 |  |  | 50 |  |  | — |  |  | 107 |
Investment in subsidiaries | 3,147 |  |  | 992 |  |  | 1,162 |  |  | — |  |  | (5,301 | ) |  | — |
Goodwill | — |  |  | 240 |  |  | 1,897 |  |  | 1,114 |  |  | — |  |  | 3,251 |
Intangible assets, net | 34 |  |  | 34 |  |  | 1,137 |  |  | 374 |  |  | — |  |  | 1,579 |
Intercompany balances | — |  |  | 5,871 |  |  | 70 |  |  | — |  |  | (5,941 | ) |  | — |
Software, net | 59 |  |  | 36 |  |  | 98 |  |  | 77 |  |  | — |  |  | 270 |
Other assets(2) | 105 |  |  | 436 |  |  | 45 |  |  | 385 |  |  | (438 | ) |  | 533 |
Total assets | $ | 3,578 |  |  | $ | 7,944 |  |  | $ | 5,188 |  |  | $ | 2,921 |  |  | $ | (11,724 | ) |  | $ | 7,907 |
Liabilities and stockholders’ (deficit) equity |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | — |  |  | $ | 285 |  |  | $ | 2 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 288 |
Other current liabilities | 79 |  |  | 215 |  |  | 250 |  |  | 246 |  |  | (33 | ) |  | 757 |
Long-term debt, excluding current portion | — |  |  | 8,474 |  |  | 8 |  |  | — |  |  | — |  |  | 8,482 |
Operating lease liabilities | 1 |  |  | 20 |  |  | 27 |  |  | 43 |  |  | — |  |  | 91 |
Other long-term liabilities | 92 |  |  | 25 |  |  | 593 |  |  | 174 |  |  | (470 | ) |  | 414 |
Intercompany balances | 5,629 |  |  | — |  |  | — |  |  | 312 |  |  | (5,941 | ) |  | — |
Total SGC stockholders’ (deficit) equity | (2,223 | ) |  | (1,075 | ) |  | 4,308 |  |  | 2,047 |  |  | (5,280 | ) |  | (2,223 | )
Noncontrolling interest | — |  |  | — |  |  | — |  |  | 98 |  |  | — |  |  | 98 |
Total liabilities and total stockholders’ (deficit) equity | $ | 3,578 |  |  | $ | 7,944 |  |  | $ | 5,188 |  |  | $ | 2,921 |  |  | $ | (11,724 | ) |  | $ | 7,907 |
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes and the Secured Notes. (2) Includes $11 million and $1 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING BALANCE SHEET As of December 31, 2018
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Assets |  |  |  |  |  |  |  |  |  |  |
Cash and cash equivalents | $ | 74 |  |  | $ | 1 |  |  | $ | — |  |  | $ | 94 |  |  | $ | (1 | ) |  | $ | 168 |
Restricted cash | — |  |  | 1 |  |  | 32 |  |  | 6 |  |  | — |  |  | 39 |
Accounts receivable, net | — |  |  | 79 |  |  | 205 |  |  | 315 |  |  | — |  |  | 599 |
Notes receivable, net | — |  |  | — |  |  | 101 |  |  | 13 |  |  | — |  |  | 114 |
Inventories | — |  |  | 40 |  |  | 82 |  |  | 111 |  |  | (17 | ) |  | 216 |
Prepaid expenses, deposits and other current assets | 6 |  |  | 63 |  |  | 92 |  |  | 72 |  |  | — |  |  | 233 |
Property and equipment, net | 31 |  |  | 112 |  |  | 219 |  |  | 218 |  |  | (33 | ) |  | 547 |
Investment in subsidiaries | 2,836 |  |  | 975 |  |  | 1,093 |  |  | — |  |  | (4,904 | ) |  | — |
Goodwill | — |  |  | 240 |  |  | 1,897 |  |  | 1,143 |  |  | — |  |  | 3,280 |
Intangible assets, net | 43 |  |  | 34 |  |  | 1,291 |  |  | 441 |  |  | — |  |  | 1,809 |
Intercompany balances | — |  |  | 6,054 |  |  | — |  |  | — |  |  | (6,054 | ) |  | — |
Software, net | 58 |  |  | 39 |  |  | 128 |  |  | 60 |  |  | — |  |  | 285 |
Other assets(2) | 110 |  |  | 404 |  |  | 46 |  |  | 308 |  |  | (440 | ) |  | 428 |
Total assets | $ | 3,158 |  |  | $ | 8,042 |  |  | $ | 5,186 |  |  | $ | 2,781 |  |  | $ | (11,449 | ) |  | $ | 7,718 |
Liabilities and stockholders’ (deficit) equity |  |  |  |  |  |  |  |  |  |  |
Current portion of long-term debt | $ | — |  |  | $ | 42 |  |  | $ | — |  |  | $ | 3 |  |  | $ | — |  |  | $ | 45 |
Other current liabilities | 64 |  |  | 162 |  |  | 248 |  |  | 254 |  |  | (26 | ) |  | 702 |
Long-term debt, excluding current portion | — |  |  | 8,991 |  |  | — |  |  | 1 |  |  | — |  |  | 8,992 |
Other long-term liabilities | 106 |  |  | 8 |  |  | 637 |  |  | 172 |  |  | (481 | ) |  | 442 |
Intercompany balances | 5,451 |  |  | — |  |  | 49 |  |  | 554 |  |  | (6,054 | ) |  | — |
Total SGC stockholders’ (deficit) equity | (2,463 | ) |  | (1,161 | ) |  | 4,252 |  |  | 1,797 |  |  | (4,888 | ) |  | (2,463 | )
Total liabilities and total stockholders’ (deficit) equity | $ | 3,158 |  |  | $ | 8,042 |  |  | $ | 5,186 |  |  | $ | 2,781 |  |  | $ | (11,449 | ) |  | $ | 7,718 |
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes (other than the 2026 Unsecured Notes, which were not issued until March 2019) and the Secured Notes.
(2) Includes $12 million and $1 million in non-current restricted cash for Guarantor Subsidiaries and Non-Guarantor Subsidiaries, respectively.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Three Months Ended September 30, 2019
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue | $ | — |  |  | $ | 139 |  |  | $ | 376 |  |  | $ | 419 |  |  | $ | (79 | ) |  | $ | 855 |
Cost of services, cost of product sales and cost of instant products(2) | — |  |  | 93 |  |  | 119 |  |  | 170 |  |  | (65 | ) |  | 317 |
SG&A | 34 |  |  | 9 |  |  | 55 |  |  | 88 |  |  | (11 | ) |  | 175 |
R&D | — |  |  | 1 |  |  | 22 |  |  | 24 |  |  | — |  |  | 47 |
D&A | 16 |  |  | 8 |  |  | 99 |  |  | 44 |  |  | (5 | ) |  | 162 |
Restructuring and other | — |  |  | 1 |  |  | 2 |  |  | 8 |  |  | — |  |  | 11 |
Operating (loss) income | (50 | ) |  | 27 |  |  | 79 |  |  | 85 |  |  | 2 |  |  | 143 |
Interest expense | — |  |  | (146 | ) |  | — |  |  | — |  |  | — |  |  | (146 | )
Gain on remeasurement of debt | — |  |  | 19 |  |  | — |  |  | — |  |  | — |  |  | 19 |
Other income (expense), net | 14 |  |  | 129 |  |  | (117 | ) |  | (27 | ) |  | — |  |  | (1 | )
Net (loss) income before equity in income of subsidiaries and income taxes | (36 | ) |  | 29 |  |  | (38 | ) |  | 58 |  |  | 2 |  |  | 15 |
Equity in income of subsidiaries | 36 |  |  | 9 |  |  | 22 |  |  | — |  |  | (67 | ) |  | — |
Income tax benefit (expense) | 14 |  |  | (8 | ) |  | 8 |  |  | (11 | ) |  | — |  |  | 3 |
Net income (loss) | 14 |  |  | 30 |  |  | (8 | ) |  | 47 |  |  | (65 | ) |  | 18 |
Less: Net income attributable to noncontrolling interest | — |  |  | — |  |  | — |  |  | 4 |  |  | — |  |  | 4 |
Net income (loss) attributable to SGC | $ | 14 |  |  | $ | 30 |  |  | $ | (8 | ) |  | $ | 43 |  |  | $ | (65 | ) |  | $ | 14 |
Net income (loss) | $ | 14 |  |  | $ | 30 |  |  | $ | (8 | ) |  | $ | 47 |  |  | $ | (65 | ) |  | $ | 18 |
Other comprehensive (loss) income | (35 | ) |  | 30 |  |  | (1 | ) |  | (61 | ) |  | 32 |  |  | (35 | )
Total comprehensive (loss) income | (21 | ) |  | 60 |  |  | (9 | ) |  | (14 | ) |  | (33 | ) |  | (17 | )
Less: comprehensive income attributable to noncontrolling interest | — |  |  | — |  |  | — |  |  | 4 |  |  | — |  |  | 4 |
Comprehensive (loss) income attributable to SGC | $ | (21 | ) |  | $ | 60 |  |  | $ | (9 | ) |  | $ | (18 | ) |  | $ | (33 | ) |  | $ | (21 | )
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes and the Secured Notes. (2) Excludes D&A.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Three Months Ended September 30, 2018
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue | $ | — |  |  | $ | 138 |  |  | $ | 404 |  |  | $ | 361 |  |  | $ | (82 | ) |  | $ | 821 |
Cost of services, cost of product sales and cost of instant products(2) | — |  |  | 90 |  |  | 119 |  |  | 160 |  |  | (68 | ) |  | 301 |
SG&A | 38 |  |  | 12 |  |  | 57 |  |  | 76 |  |  | (13 | ) |  | 170 |
R&D | — |  |  | — |  |  | 21 |  |  | 29 |  |  | — |  |  | 50 |
D&A | 11 |  |  | 9 |  |  | 106 |  |  | 45 |  |  | (5 | ) |  | 166 |
Restructuring and other | 320 |  |  | 3 |  |  | 4 |  |  | 12 |  |  | — |  |  | 339 |
Operating (loss) income | (369 | ) |  | 24 |  |  | 97 |  |  | 39 |  |  | 4 |  |  | (205 | )
Interest expense | — |  |  | (147 | ) |  | — |  |  | — |  |  | — |  |  | (147 | )
Gain on remeasurement of debt | — |  |  | (4 | ) |  | — |  |  | — |  |  | — |  |  | (4 | )
Other income (expense), net | 16 |  |  | 130 |  |  | (123 | ) |  | (19 | ) |  | — |  |  | 4 |
Net (loss) income before equity in income of subsidiaries and income taxes | (353 | ) |  | 3 |  |  | (26 | ) |  | 20 |  |  | 4 |  |  | (352 | )
Equity in income (loss) of subsidiaries | — |  |  | 4 |  |  | (10 | ) |  | — |  |  | 6 |  |  | — |
Income tax benefit (expense) | 1 |  |  | (1 | ) |  | 6 |  |  | (6 | ) |  | — |  |  | — |
Net (loss) income | $ | (352 | ) |  | $ | 6 |  |  | $ | (30 | ) |  | $ | 14 |  |  | $ | 10 |  |  | $ | (352 | )
Other comprehensive (loss) income | (5 | ) |  | 11 |  |  | (10 | ) |  | (2 | ) |  | 1 |  |  | (5 | )
Comprehensive (loss) income | $ | (357 | ) |  | $ | 17 |  |  | $ | (40 | ) |  | $ | 12 |  |  | $ | 11 |  |  | $ | (357 | )
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes (other than the 2026 Unsecured Notes, which were not issued until March 2019) and the Secured Notes. (2) Excludes D&A.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Nine Months Ended September 30, 2019
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue | $ | — |  |  | $ | 444 |  |  | $ | 1,092 |  |  | $ | 1,211 |  |  | $ | (210 | ) |  | $ | 2,537 |
Cost of services, cost of product sales and cost of instant products(2) | — |  |  | 288 |  |  | 329 |  |  | 498 |  |  | (170 | ) |  | 945 |
SG&A | 100 |  |  | 29 |  |  | 162 |  |  | 276 |  |  | (32 | ) |  | 535 |
R&D | — |  |  | 3 |  |  | 64 |  |  | 75 |  |  | — |  |  | 142 |
D&A | 40 |  |  | 33 |  |  | 302 |  |  | 136 |  |  | (14 | ) |  | 497 |
Restructuring and other | 2 |  |  | 2 |  |  | 5 |  |  | 15 |  |  | — |  |  | 24 |
Operating (loss) income | (142 | ) |  | 89 |  |  | 230 |  |  | 211 |  |  | 6 |  |  | 394 |
Interest expense | — |  |  | (447 | ) |  | — |  |  | — |  |  | — |  |  | (447 | )
Loss on debt financing transactions | — |  |  | (60 | ) |  | — |  |  | — |  |  | — |  |  | (60 | )
Gain on remeasurement of debt | — |  |  | 21 |  |  | — |  |  | — |  |  | — |  |  | 21 |
Other income (expense), net | 50 |  |  | 392 |  |  | (360 | ) |  | (63 | ) |  | — |  |  | 19 |
Net (loss) income before equity in income of subsidiaries and income taxes | (92 | ) |  | (5 | ) |  | (130 | ) |  | 148 |  |  | 6 |  |  | (73 | )
Equity in income of subsidiaries | 12 |  |  | 18 |  |  | 45 |  |  | — |  |  | (75 | ) |  | — |
Income tax (expense) benefit | (7 | ) |  | 1 |  |  | 30 |  |  | (32 | ) |  | — |  |  | (8 | )
Net (loss) income | (87 | ) |  | 14 |  |  | (55 | ) |  | 116 |  |  | (69 | ) |  | (81 | )
Less: Net income attributable to noncontrolling interest | — |  |  | — |  |  | — |  |  | 6 |  |  | — |  |  | 6 |
Net (loss) income attributable to SGC | $ | (87 | ) |  | $ | 14 |  |  | $ | (55 | ) |  | $ | 110 |  |  | $ | (69 | ) |  | $ | (87 | )
Net (loss) income | $ | (87 | ) |  | $ | 14 |  |  | $ | (55 | ) |  | $ | 116 |  |  | $ | (69 | ) |  | $ | (81 | )
Other comprehensive (loss) income | (35 | ) |  | 24 |  |  | (2 | ) |  | (56 | ) |  | 34 |  |  | (35 | )
Total comprehensive (loss) income | (122 | ) |  | 38 |  |  | (57 | ) |  | 60 |  |  | (35 | ) |  | (116 | )
Less: comprehensive income attributable to noncontrolling interest | — |  |  | — |  |  | — |  |  | 6 |  |  | — |  |  | 6 |
Comprehensive (loss) income attributable to SGC | $ | (122 | ) |  | $ | 38 |  |  | $ | (57 | ) |  | $ | 54 |  |  | $ | (35 | ) |  | $ | (122 | )
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes and the Secured Notes. (2) Excludes D&A.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME Nine Months Ended September 30, 2018
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Revenue | $ | — |  |  | $ | 404 |  |  | $ | 1,196 |  |  | $ | 1,107 |  |  | $ | (229 | ) |  | $ | 2,478 |
Cost of services, cost of product sales and cost of instant products(2) | — |  |  | 263 |  |  | 369 |  |  | 472 |  |  | (190 | ) |  | 914 |
SG&A | 119 |  |  | 32 |  |  | 166 |  |  | 238 |  |  | (40 | ) |  | 515 |
R&D | — |  |  | 1 |  |  | 66 |  |  | 85 |  |  | 1 |  |  | 153 |
D&A | 32 |  |  | 24 |  |  | 339 |  |  | 143 |  |  | (11 | ) |  | 527 |
Restructuring and other | 375 |  |  | — |  |  | 8 |  |  | 42 |  |  | (1 | ) |  | 424 |
Operating (loss) income | (526 | ) |  | 84 |  |  | 248 |  |  | 127 |  |  | 12 |  |  | (55 | )
Interest expense | — |  |  | (448 | ) |  | — |  |  | — |  |  | — |  |  | (448 | )
Loss on debt financing transactions | — |  |  | (93 | ) |  | — |  |  | — |  |  | — |  |  | (93 | )
Gain on remeasurement of debt | — |  |  | 29 |  |  | — |  |  | — |  |  | — |  |  | 29 |
Other income (expense), net | 49 |  |  | 399 |  |  | (375 | ) |  | (59 | ) |  | — |  |  | 14 |
Net (loss) income before equity in income of subsidiaries and income taxes | (477 | ) |  | (29 | ) |  | (127 | ) |  | 68 |  |  | 12 |  |  | (553 | )
Equity in (loss) income of subsidiaries | (60 | ) |  | 22 |  |  | (17 | ) |  | — |  |  | 55 |  |  | — |
Income tax (expense) benefit | (22 | ) |  | 7 |  |  | 27 |  |  | (18 | ) |  | — |  |  | (6 | )
Net (loss) income | $ | (559 | ) |  | $ | — |  |  | $ | (117 | ) |  | $ | 50 |  |  | $ | 67 |  |  | $ | (559 | )
Other comprehensive (loss) income | (37 | ) |  | 23 |  |  | (23 | ) |  | (48 | ) |  | 48 |  |  | (37 | )
Comprehensive (loss) income | $ | (596 | ) |  | $ | 23 |  |  | $ | (140 | ) |  | $ | 2 |  |  | $ | 115 |  |  | $ | (596 | )
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes (other than the 2026 Unsecured Notes, which were not issued until March 2019) and the Secured Notes. (2) Excludes D&A.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Nine Months Ended September 30, 2019
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Net cash (used in) provided by operating activities | $ | (36 | ) |  | $ | 77 |  |  | $ | 146 |  |  | $ | 216 |  |  | $ | — |  |  | $ | 403 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Capital expenditures | (17 | ) |  | (22 | ) |  | (85 | ) |  | (83 | ) |  | — |  |  | (207 | )
Distributions of capital from equity investments | — |  |  | — |  |  | — |  |  | 18 |  |  | — |  |  | 18 |
Additions to equity method investments | — |  |  | (1 | ) |  | — |  |  | — |  |  | — |  |  | (1 | )
Other, principally change in intercompany investing activities | — |  |  | 268 |  |  | (61 | ) |  | — |  |  | (207 | ) |  | — |
Net cash (used in) provided by investing activities | (17 | ) |  | 245 |  |  | (146 | ) |  | (65 | ) |  | (207 | ) |  | (190 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |
Payments of long-term debt, net of proceeds | — |  |  | (306 | ) |  | — |  |  | (2 | ) |  | — |  |  | (308 | )
Payments of debt issuance and deferred financing costs | — |  |  | (14 | ) |  | — |  |  | (1 | ) |  | — |  |  | (15 | )
Payments on license obligations | (20 | ) |  | (1 | ) |  | (5 | ) |  | — |  |  | — |  |  | (26 | )
Sale of future revenue | — |  |  | — |  |  | 11 |  |  | — |  |  | — |  |  | 11 |
Net proceeds from the sale of SciPlay common stock | — |  |  | — |  |  | — |  |  | 342 |  |  | — |  |  | 342 |
Payments of deferred SciPlay common stock offering costs | — |  |  | — |  |  | — |  |  | (9 | ) |  | — |  |  | (9 | )
Net redemptions of common stock under stock-based compensation plans and other | — |  |  | (2 | ) |  | (2 | ) |  | (2 | ) |  | — |  |  | (6 | )
Other, principally change in intercompany financing activities | 193 |  |  | — |  |  | — |  |  | (400 | ) |  | 207 |  |  | — |
Net cash provided by (used in) financing activities | 173 |  |  | (323 | ) |  | 4 |  |  | (72 | ) |  | 207 |  |  | (11 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash | — |  |  | — |  |  | — |  |  | (1 | ) |  | — |  |  | (1 | )
Increase (decrease) in cash, cash equivalents and restricted cash | 120 |  |  | (1 | ) |  | 4 |  |  | 78 |  |  | — |  |  | 201 |
Cash, cash equivalents and restricted cash, beginning of period | 74 |  |  | 2 |  |  | 44 |  |  | 101 |  |  | (1 | ) |  | 220 |
Cash, cash equivalents and restricted cash, end of period | $ | 194 |  |  | $ | 1 |  |  | $ | 48 |  |  | $ | 179 |  |  | $ | (1 | ) |  | $ | 421 |
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes and the Secured Notes.
SCIENTIFIC GAMES CORPORATION AND SUBSIDIARIES SUPPLEMENTAL CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS Nine Months Ended September 30, 2018
| SGC (Parent) |  | SGI (Issuer 1) |  | Guarantor Subsidiaries |  | Non-Guarantor Subsidiaries |  | Eliminating Entries |  | Consolidated
Net cash (used in) provided by operating activities | $ | (56 | ) |  | $ | 30 |  |  | $ | 153 |  |  | $ | 231 |  |  | $ | (2 | ) |  | $ | 356 |
Cash flows from investing activities: |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Capital expenditures | (30 | ) |  | (57 | ) |  | (122 | ) |  | (84 | ) |  | — |  |  | (293 | )
Acquisitions of businesses and assets, net of cash acquired | — |  |  | — |  |  | (10 | ) |  | (264 | ) |  | — |  |  | (274 | )
Distributions of capital from equity investments | — |  |  | — |  |  | — |  |  | 24 |  |  | — |  |  | 24 |
Additions to equity method investments | — |  |  | (2 | ) |  | — |  |  | (74 | ) |  | — |  |  | (76 | )
Other, principally change in intercompany investing activities | — |  |  | 91 |  |  | (15 | ) |  | — |  |  | (76 | ) |  | — |
Net cash (used in) provided by investing activities | (30 | ) |  | 32 |  |  | (147 | ) |  | (398 | ) |  | (76 | ) |  | (619 | )
Cash flows from financing activities: |  |  |  |  |  |  |  |  |  |  |
Proceeds net of payments on long-term debt | — |  |  | (24 | ) |  | — |  |  | (6 | ) |  | — |  |  | (30 | )
Repayment of assumed NYX debt | — |  |  | — |  |  | — |  |  | (288 | ) |  | — |  |  | (288 | )
Payments of debt issuance and deferred financing costs | — |  |  | (39 | ) |  | — |  |  | — |  |  | — |  |  | (39 | )
Payments on license obligations | (20 | ) |  | — |  |  | (2 | ) |  | — |  |  | — |  |  | (22 | )
Net redemptions of common stock under stock-based compensation plans and other | (22 | ) |  | — |  |  | (2 | ) |  | — |  |  | — |  |  | (24 | )
Other, principally change in intercompany financing activities | (565 | ) |  | — |  |  | — |  |  | 489 |  |  | 76 |  |  | — |
Net cash (used in) provided by financing activities | (607 | ) |  | (63 | ) |  | (4 | ) |  | 195 |  |  | 76 |  |  | (403 | )
Effect of exchange rate changes on cash, cash equivalents and restricted cash | — |  |  | — |  |  | — |  |  | (2 | ) |  | — |  |  | (2 | )
(Decrease) increase in cash, cash equivalents and restricted cash | (693 | ) |  | (1 | ) |  | 2 |  |  | 26 |  |  | (2 | ) |  | (668 | )
Cash, cash equivalents and restricted cash, beginning of period | 732 |  |  | 1 |  |  | 44 |  |  | 60 |  |  | (3 | ) |  | 834 |
Cash, cash equivalents and restricted cash end of period | $ | 39 |  |  | $ | — |  |  | $ | 46 |  |  | $ | 86 |  |  | $ | (5 | ) |  | $ | 166 |
(1) Issuer of obligations under the Subordinated Notes, the Unsecured Notes (other than the 2026 Unsecured Notes, which were not issued until March 2019) and the Secured Notes.

X
- Definition -- None. No documentation exists for this element. -- + References No definition available. + Details
Name: | sgms_FinancialInformationForGuarantorSubsidiariesAndNonGuarantorSubsidiariesAbstract
Namespace Prefix: | sgms_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the condensed financial statements (balance sheet, income statement and statement of cash flows), normally using the registrant (parent) as the sole domain member. If condensed consolidating financial statements are being presented, other domain members (in addition to parent) such as guarantor subsidiaries, non-guarantor subsidiaries, and the consolidation eliminations, will be included in order that the respective monetary amounts for each of the domains will aggregate to the respective amounts on the consolidated financial statements. The line items are the various captions used to compile the condensed financial statements. Using extensions, most, if not all, of the elements representing condensed financial statement captions will be the same as those used for the consolidated financial statements captions. + References No definition available. + Details
Name: | sgms_FinancialInformationForGuarantorSubsidiariesAndNonGuarantorSubsidiariesDisclosureTextBlock
Namespace Prefix: | sgms_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration